Heavy or prolong menstrual bleeding and Injection site haematoma

Summary:

Injection site haematoma is found among people with Heavy or prolong menstrual bleeding, especially for people who are female, 30-39 old.

The study analyzes which people have Injection site haematoma with Heavy or prolong menstrual bleeding. It is created by eHealthMe based on reports of 9 people who have Heavy or prolong menstrual bleeding from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

9 people who have Heavy Or Prolong Menstrual Bleeding and Injection Site Haematoma are studied.

What is Heavy or prolong menstrual bleeding?

Heavy or prolong menstrual bleeding is found to be associated with 1,778 drugs and 1,178 conditions by eHealthMe.

What is Injection site haematoma?

Injection site haematoma (localized swelling filled with blood at injection site) is found to be associated with 1,166 drugs and 823 conditions by eHealthMe.

Number of Injection site haematoma in Heavy or prolong menstrual bleeding reports submitted per year:

Would you have Injection site haematoma when you have Heavy or prolong menstrual bleeding?

Gender of people who have Heavy Or Prolong Menstrual Bleeding and experienced Injection Site Haematoma *:

female: 100 %
male: 0.0 %

Age of people who have Heavy Or Prolong Menstrual Bleeding and experienced Injection Site Haematoma *:

Common co-existing conditions for these people *:

Vaginal Bleeding: 9 people, 100.00%
Hypersensitivity: 9 people, 100.00%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 9 people, 100.00%
Dysmenorrhea (painful menstruation): 9 people, 100.00%
Cyst (a closed sac): 9 people, 100.00%
Asthma: 9 people, 100.00%

Common drugs taken by these people *:

Lupron Depot: 9 people, 100.00%
Zyrtec: 6 people, 66.67%
Xyzal: 6 people, 66.67%
Singulair: 6 people, 66.67%
Albuterol: 6 people, 66.67%
Montelukast Sodium: 3 people, 33.33%
Levocetirizine Dihydrochloride: 3 people, 33.33%
Cetirizine Hydrochloride: 3 people, 33.33%
Albuterol Sulfate: 1 person, 11.11%

Common symptoms for these people *:

Weight Increased: 9 people, 100.00%
Eyelid Twitch (spontaneous and uncontrolled spasms of the muscles): 9 people, 100.00%
Joint Pain: 9 people, 100.00%
Weakness: 9 people, 100.00%
Insomnia (sleeplessness): 9 people, 100.00%
Injection Site Pain: 9 people, 100.00%
Injection Site Irritation: 9 people, 100.00%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 100.00%
Hot Flush (sudden feelings of heat): 9 people, 100.00%
Headache (pain in head): 9 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site haematoma?

Check whether Injection site haematoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .

Related studies

Treatments, associated drugs and conditions:

Heavy or prolong menstrual bleeding (38,011 reports)
Injection site haematoma (16,495 reports)

COVID vaccines that are related to Injection site haematoma:

Common drugs associated with Injection site haematoma:

All the drugs that are associated with Injection site haematoma:

Injection site haematoma (1,166 drugs)

Common conditions associated with Injection site haematoma:

All the conditions that are associated with Injection site haematoma:

Injection site haematoma (823 conditions)

How the study uses the data?

The study is based on Injection site haematoma and Heavy or prolong menstrual bleeding, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.